Vincent O'Neill

BioXcel Therapeutics, Inc.

Insider activity · 24 months0 buys1 saleCumulative net flow

Dec 24 · 0 buys · 1 saleJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 salesNov 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (21 ops.)

€4.1M

Latest filing published 17 Dec 2024 for BioXcel Therapeutics, Inc., €55.

Filing timeline

BuySale

Vincent O'Neill

Insider track record

Disclosed buys

Disclosed sells

Signal history

Vincent O'Neill: trading record in brief

Vincent O'Neill is a declared insider of BioXcel Therapeutics, Inc., with filings sourced from SEC (Form 4). In total, 36 filings cover trades dated from 28 December 2020 to 16 December 2024.

Every open-market trade on record is a sale: 21 sales worth €4.1M. Outside the open market, there are 1 share grant and 14 option exercises. 2024 to date brings no purchases and 5 sales.

The newest entry dates from 17 December 2024: an open-market sale of €55, in BioXcel Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Vincent O'Neill

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

BioXcel Therapeutics, Inc. (US)

Declarations36 total

▼
Vincent O'Neill
See RemarksExecutives16 Dec 2024BioXcel Therapeutics, Inc.
58 USD20SEC
165 shares@ US$0.35230.2% of flowCommon StockSEC:0001104659-24-129464:1
◇
Vincent O'Neill
See RemarksExecutives14 Dec 2024BioXcel Therapeutics, Inc.
0SEC
521 sharesCommon StockSEC:0001104659-24-129464:0
▼
Vincent O'Neill
See RemarksExecutives3 Oct 2024BioXcel Therapeutics, Inc.
3,056 USD21SEC
5,556 shares@ US$0.557.6% of flowCommon StockSEC:0001104659-24-106060:1
◆
Vincent O'Neill
See RemarksExecutives17 Sept 2024BioXcel Therapeutics, Inc.
0SEC
21,250 sharesCommon StockSEC:0001104659-24-106060:0
▼
Vincent O'Neill
See RemarksExecutives16 Sept 2024BioXcel Therapeutics, Inc.
95 USD20SEC
138 shares@ US$0.69080.2% of flowCommon StockSEC:0001104659-24-100747:1
◇
Vincent O'Neill
See RemarksExecutives14 Sept 2024BioXcel Therapeutics, Inc.
0SEC
521 sharesCommon StockSEC:0001104659-24-100747:0
▼
Vincent O'Neill
See RemarksExecutives17 Jun 2024BioXcel Therapeutics, Inc.
200 USD20SEC
155 shares@ US$1.290.5% of flowCommon StockSEC:0001104659-24-073000:1
◇
Vincent O'Neill
See RemarksExecutives14 Jun 2024BioXcel Therapeutics, Inc.
0SEC
521 sharesCommon StockSEC:0001104659-24-073000:0
▼
Vincent O'Neill
See RemarksExecutives4 Apr 2024BioXcel Therapeutics, Inc.
432 USD2SEC
165 shares@ US$2.620.0% of flowCommon StockSEC:0001104659-24-044862:2
◇
Vincent O'Neill
See RemarksExecutives15 Mar 2024BioXcel Therapeutics, Inc.
0SEC
2,250 sharesCommon StockSEC:0001104659-24-044862:1
◇
Vincent O'Neill
See RemarksExecutives14 Mar 2024BioXcel Therapeutics, Inc.
0SEC
521 sharesCommon StockSEC:0001104659-24-044862:0
◇
Vincent O'Neill
Chief Medical OfficerExecutives14 Dec 2023BioXcel Therapeutics, Inc.
0SEC
521 sharesCommon StockSEC:0001104659-23-126916:0
◇
Vincent O'Neill
Chief Medical OfficerExecutives14 Sept 2023BioXcel Therapeutics, Inc.
0SEC
521 sharesCommon StockSEC:0001104659-23-101637:0
◇
Vincent O'Neill
Chief Medical OfficerExecutives14 Jun 2023BioXcel Therapeutics, Inc.
0SEC
521 sharesCommon StockSEC:0001104659-23-072395:0
▼
Vincent O'Neill
Chief Medical OfficerExecutives15 Mar 2023BioXcel Therapeutics, Inc.
16,647 USD26SEC
845 shares@ US$19.700.1% of flowCommon StockSEC:0001104659-23-033402:1
◇
Vincent O'Neill
Chief Medical OfficerExecutives14 Mar 2023BioXcel Therapeutics, Inc.
0SEC
2,084 sharesCommon StockSEC:0001104659-23-033402:0
▼
Vincent O'Neill
Chief Medical OfficerExecutives20 Jan 2023BioXcel Therapeutics, Inc.
891,390 USD0SEC
29,713 shares@ US$30.00Common StockSEC:0001104659-23-006295:1
◇
Vincent O'Neill
Chief Medical OfficerExecutives20 Jan 2023BioXcel Therapeutics, Inc.
12,182 USD19SEC
29,713 shares@ US$0.41100.0% of flowCommon StockSEC:0001104659-23-006295:0
◇
Vincent O'Neill
Chief Medical OfficerExecutives17 Feb 2021BioXcel Therapeutics, Inc.
6,150 USD13SEC
15,000 shares@ US$0.4115.2% of flowCommon StockSEC:0001104659-21-025878:0
▼
Vincent O'Neill
Chief Medical OfficerExecutives17 Feb 2021BioXcel Therapeutics, Inc.
123,671 USD23SEC
2,300 shares@ US$53.770.1% of flowCommon StockSEC:0001104659-21-025878:2
▼
Vincent O'Neill
Chief Medical OfficerExecutives17 Feb 2021BioXcel Therapeutics, Inc.
34,302 USD23SEC
600 shares@ US$57.170.1% of flowCommon StockSEC:0001104659-21-025878:6
◇
Vincent O'Neill
Chief Medical OfficerExecutives17 Feb 2021BioXcel Therapeutics, Inc.
110,000 USD0SEC
10,000 shares@ US$11.00Common StockSEC:0001104659-21-025878:1
▼
Vincent O'Neill
Chief Medical OfficerExecutives17 Feb 2021BioXcel Therapeutics, Inc.
307,915 USD0SEC
5,655 shares@ US$54.45Common StockSEC:0001104659-21-025878:3
▼
Vincent O'Neill
Chief Medical OfficerExecutives17 Feb 2021BioXcel Therapeutics, Inc.
381,740 USD0SEC
6,872 shares@ US$55.55Common StockSEC:0001104659-21-025878:4
▼
Vincent O'Neill
Chief Medical OfficerExecutives17 Feb 2021BioXcel Therapeutics, Inc.
541,832 USD0SEC
9,573 shares@ US$56.60Common StockSEC:0001104659-21-025878:5

25 of 36 declarations

Vincent O'Neill

Insider track record

Vincent O'Neill: trading record in brief

Companies and markets linked to Vincent O'Neill

Related entities